Literature DB >> 30421619

Editor's Choice- Reperfusion cardiac arrhythmias and their relation to reperfusion-induced cell death.

Kirian van der Weg1, Frits W Prinzen2, Anton Pm Gorgels1,2.   

Abstract

Reperfusion does not only salvage ischaemic myocardium but can also cause additional cell death which is called lethal reperfusion injury. The time of reperfusion is often accompanied by ventricular arrhythmias, i.e. reperfusion arrhythmias. While both conditions are seen as separate processes, recent research has shown that reperfusion arrhythmias are related to larger infarct size. The pathophysiology of fatal reperfusion injury revolves around intracellular calcium overload and reactive oxidative species inducing apoptosis by opening of the mitochondrial protein transition pore. The pathophysiological basis for reperfusion arrhythmias is the same intracellular calcium overload as that causing fatal reperfusion injury. Therefore both conditions should not be seen as separate entities but as one and the same process resulting in two different visible effects. Reperfusion arrhythmias could therefore be seen as a potential marker for fatal reperfusion injury.

Entities:  

Keywords:  Myocardial infarction; arrhythmias; myocardial reperfusion injury; pathophysiology

Mesh:

Year:  2018        PMID: 30421619     DOI: 10.1177/2048872618812148

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  10 in total

1.  Soluble guanylate cyclase (sGC) stimulator vericiguat alleviates myocardial ischemia-reperfusion injury by improving microcirculation.

Authors:  Yun Cai; Beijian Zhang; Adilan Shalamu; Tingwen Gao; Junbo Ge
Journal:  Ann Transl Med       Date:  2022-06

2.  Critical Requirements for the Initiation of a Cardiac Arrhythmia in Rat Ventricle: How Many Myocytes?

Authors:  Aman Ullah; Minh Tuan Hoang-Trong; William Jonathan Lederer; Raimond L Winslow; Mohsin Saleet Jafri
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

3.  Ventricular fibrillation storm after revascularization of chronic total occlusion of the left anterior descending artery: is this reperfusion arrhythmia?

Authors:  Xingji Liu; Binay Kumar Adhikari; Tianlong Chen; Yonggang Wang; Quan Liu; Shudong Wang
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

Review 4.  ArrhythmoGenoPharmacoTherapy.

Authors:  Arpad Tosaki
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

Review 5.  Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models.

Authors:  Andrea Baehr; Nikolai Klymiuk; Christian Kupatt
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

6.  Ischemic Postconditioning Reduces Reperfusion Arrhythmias by Adenosine Receptors and Protein Kinase C Activation but Is Independent of KATP Channels or Connexin 43.

Authors:  Emiliano Raúl Diez; Jose Antonio Sánchez; Natalia Jorgelina Prado; Amira Zulma Ponce Zumino; David García-Dorado; Roberto Miguel Miatello; Antonio Rodríguez-Sinovas
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

Review 7.  Mitochondrial Pathobiology and Metabolic Remodeling in Progression to Overt Systolic Heart Failure.

Authors:  Antoine H Chaanine; Thierry H LeJemtel; Patrice Delafontaine
Journal:  J Clin Med       Date:  2020-11-06       Impact factor: 4.241

8.  IRF2 contributes to myocardial infarction via regulation of GSDMD induced pyroptosis.

Authors:  Yongxing Li; Yan Wang; Hua Guo; Qinghua Wu; Yamin Hu
Journal:  Mol Med Rep       Date:  2021-12-08       Impact factor: 2.952

Review 9.  Role of miRNA-1 and miRNA-21 in Acute Myocardial Ischemia-Reperfusion Injury and Their Potential as Therapeutic Strategy.

Authors:  Eranthi Jayawardena; Lejla Medzikovic; Gregoire Ruffenach; Mansoureh Eghbali
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 6.208

Review 10.  Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection.

Authors:  Nikolaos Kosmas; Antonis S Manolis; Nikolaos Dagres; Efstathios K Iliodromitis
Journal:  Europace       Date:  2020-09-01       Impact factor: 5.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.